Advertisement

Chagas diseases: Opportunities for internists

  • José M. Ramos
    Correspondence
    Department of Internal Medicine, Hospital General Universitario de Alicante, Calle Pintor Baeza, 12, 03012 Alicante, Spain.
    Affiliations
    Department of Internal Medicine, Hospital General Universitario de Alicante, Alicante, Spain
    Department of Medicine, Miguel Hernández University of Elche, San Juan Campus, Spain
    Search for articles by this author
Published:September 08, 2017DOI:https://doi.org/10.1016/j.ejim.2017.09.005
      We read with interest the recent paper, “Chagas disease in Europe: A review for the internist in the globalized world”, published in your journal. Antinori and colleagues masterfully review Chagas disease to present a vision of the disease's epidemiology in Europe and in particular the aspects related to blood-derived and congenital transmission, clinical forms and their reactivation in immunocompromised patients, diagnostic aspects, management, and treatment [
      • Antinori S.
      • Galimberti L.
      • Bianco R.
      • Grande R.
      • Galli M.
      • Corbellino M.
      Chagas disease in Europe: a review for the internist in the globalized world.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Antinori S.
        • Galimberti L.
        • Bianco R.
        • Grande R.
        • Galli M.
        • Corbellino M.
        Chagas disease in Europe: a review for the internist in the globalized world.
        Eur J Intern Med. 2017 May 11; (pii: S0953-6205(17)30177-2)
        http://dx.doi.org/10.1016/j.ejim.2017.05.001
        • Requena-Méndez A.
        • Bussion S.
        • Aldasoro E.
        • Jackson Y.
        • Angheben A.
        • Moore D.
        • et al.
        Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centers in Europe: a Markov model analysis.
        Lancet Glob Health. 2017; 5: e439-e447https://doi.org/10.1016/S2214-109X(17)30073-6
        • Ramos J.M.
        • Pinargote H.
        • Andreu M.
        • Sastre J.
        • Torrus D.
        • Martinez-Escoriza J.C.
        • et al.
        Prevalence of Trypanosoma cruzi infection in Latin American pregnant women and level of compliance of the Valencian Health Programme in the city of Alicante.
        Epidemiol Infect. 2014; 142: 888-890https://doi.org/10.1017/S0950268813001921
        • Ramos J.M.
        • Ponce Y.
        • Gallegos I.
        • Flóres-Chávez M.
        • Cañavate C.
        • Gutiérrez F.
        Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia.
        Pathog Glob Health. 2012; 106: 102-106https://doi.org/10.1179/2047773212Y.0000000013
        • Ramos J.M.
        • León R.
        • Andreu M.
        • de las Parras E.R.
        • Rodríguez-Díaz J.C.
        • Esteban Á.
        • et al.
        Serological study of Trypanosoma cruzi, Strongyloides stercoralis, HIV, human T cell lymphotropic virus (HTLV) and syphilis infections in asymptomatic Latin-American immigrants in Spain.
        Trans R Soc Trop Med Hyg. 2015; 109: 447-453https://doi.org/10.1093/trstmh/trv043